This approval represents a significant regulatory milestone, making Proliv™Rx the first and only at-home neuromodulation ...
The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment ...
MedPage Today on MSN
FDA Approves At-Home Device for Treatment-Resistant Depression
The FDA approved a prescription at-home brain neuromodulation therapy as an adjunctive depression treatment for adults, maker ...
EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance36% to 38% Annual YoY HIFU Revenue ...
Padma Bhushan Begum Parveen Sultana, the revered classical vocalist, was recently in Delhi for the Sangeet Nritya Mahotsav.
News-Medical.Net on MSN
Implanted vagus nerve stimulation device offers lasting relief for severe depression
About 20% of U.S. adults experience major depression in their lifetime. For most people, symptoms improve within a few ...
Research shows that vagus nerve stimulation can provide long-lasting benefits for patients who do not respond to conventional treatments Around 20% of adults in the United States will experience major ...
Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today ...
About 20% of U.S. adults experience major depression in their lifetime. For most people, symptoms improve within a few ...
Jinxing Li and Christopher H. Contag delve into magnetobiology, which utilizes magnetic fields to manipulate and control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback